Upgrade to SI Premium - Free Trial

Blackrock Broad Inv Gr 2009 (BCT)

12.54 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

BriaCell's Phase 3 breast cancer study clears seventh DSMB review September 14, 2026 7:30 AM - StreetInsider Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study September 14, 2026 7:30 AM - StreetInsider BriaCell adds Memorial Sloan Kettering to Phase 3 breast cancer trial September 8, 2026 7:30 AM - StreetInsider BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center September 8, 2026 7:30 AM - StreetInsider Full Article List